United States · FDA National Drug Code directory
Ondansetron Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-2053_2bae2620-0ac5-7e55-e063-6394a90ad47c
- Product NDC
- 68071-2053
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- NuCare Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070731
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, FILM COATED in 1 BOTTLE (68071-2053-1) · 68071-2053-1
- 20 TABLET, FILM COATED in 1 BOTTLE (68071-2053-2) · 68071-2053-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →